Literature DB >> 16003359

Stem cells--a hard sell to investors.

Lutz B Giebel1.   

Abstract

Mesh：

Year:  2005        PMID： 16003359     DOI： 10.1038/nbt0705-798

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

1.  Commercialization and stem cell research: a review of emerging issues.

Authors:  Sarah Burningham; Adam Ollenberger; Timothy Caulfield
Journal:  Stem Cells Dev       Date:  2013-12       Impact factor: 3.272

Review 2.  Concise review: cell therapies: the route to widespread adoption.

Authors:  Lucy Foley; Michael Whitaker
Journal:  Stem Cells Transl Med       Date:  2012-05-09       Impact factor: 6.940

3.  Therapies of the state.

Authors:  Beth Schachter
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 4.  Neurodegeneration and cell replacement.

Authors:  Brandi K Ormerod; Theo D Palmer; Maeve A Caldwell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

Review 5.  Cardiovascular disease models: A game changing paradigm in drug discovery and screening.

Authors:  Houman Savoji; Mohammad Hossein Mohammadi; Naimeh Rafatian; Masood Khaksar Toroghi; Erika Yan Wang; Yimu Zhao; Anastasia Korolj; Samad Ahadian; Milica Radisic
Journal:  Biomaterials       Date:  2018-10-01       Impact factor: 12.479

6.  Patents and misplaced angst: lessons for translational stem cell research from genomics.

Authors:  Debra J H Mathews; Robert Cook-Deegan; Tania Bubela
Journal:  Cell Stem Cell       Date:  2013-05-02       Impact factor: 24.633

7.  Gene-enhanced tissue engineering for dental hard tissue regeneration: (1) overview and practical considerations.

Authors:  Paul C Edwards; James M Mason
Journal:  Head Face Med       Date:  2006-05-15       Impact factor: 2.151
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.